top of page

BRIDGE

PHASE II TRIAL OF DURVALUMAB AND CHEMOTHERAPY INDUCTION FOLLOWED BY DURVALUMAB AND RADIOTHERAPY IN LARGE VOLUME STAGE III NSCLC

CLINICAL TRIAL DETAILS

STAGE III A-B-C (ACCORDING TO VERSION 8 OF THE INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER STAGING MANUAL IN THORACIC ONCOLOGY) NSCLC PATIENTS NOT ELIGIBLE FOR SURGERY OR CONCURRENT CHEMORADIATION AT DIAGNOSIS BECAUSE OF LARGE TUMOR VOLUMES. THIS IS A MULTICENTRIC, OPEN LABEL, SINGLE ARM, SIMON 2 STAGES PHASE 2 TRIAL.

BRIDGE AT CLINICALTRIALS.GOV

COUNTRY

STATUS

TUMOR TYPE

PHASE

N

SITES

NSCLC

3

65

II

Spain, France, Italy

Recruitment

PRESS RELEASE

home_fondo_you_barra.jpg

-

SCIENTIFIC IMPACT

home_fondo_you_barra.jpg

-

BLOG ARTICLES RELATED

home_fondo_you_barra.jpg

-

TRIAL SITES

home_fondo_you_barra.jpg
Vall d'Hebron Institute of Oncology (VHIO) (Spain) Gustave Roussy (France) Institute Tumori Mario Negrini (Italy)
bottom of page